Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

NRX Pharmaceuticals, Inc. Warrant (NRXPW)

Pharmaceutical Preparations

https://nrxpharma.com

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.

1201 ORANGE STREET, SUITE 600
WILMINGTON, DE

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/25/2021

Market Cap

17,059,828

Shares Outstanding

83,920,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.2600

Last Div

0.0000

Range

0.0513-0.06

Chg

-0.0100

Avg Vol

N/A

Mkt Cap

17059828

Exch

NASDAQ

Country

US

Phone

484 254 6134

DCF Diff

2.3427

DCF

-0.6027

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.7365

P/FV

-1012.2290

Div Yield %

0.0000

P/E

-750.0667

PEG

1.1774

Payout

0.0000

Current Ratio

0.9731

Quick Ratio

0.9731

Cash Ratio

0.3785

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

457618.7500

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0563

ROA

-4.7149

ROE

1.9311

ROCE

-93.4217

NI/EBT

1.0000

EBT/EBIT

1.0669

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-66.4629

CF/Debt

0.0000

Equity Multi

-0.2862

Rec Turnover

0.0000

Pay Turnover

0.0008

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0011

FCF/Share

-0.0011

Cash/Share

0.0002

OCF/Sales

0.0000

FCF/OCF

0.9998

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-5713.5000

Div&CapEx Cov

-5713.5000

P/BV

-1012.2290

P/B

-1012.2290

P/S

0.0000

P/E

-750.0667

P/FCF

-1.6578

P/OCF

-1629.1156

P/CF

-1629.1156

PEG

1.1774

P/S

0.0000

EV Multiple

-0.7365

P/FV

-1012.2290

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation